Science goes further
A new frontier
in weight management
Serenovo makes next-generation weight loss simple with an easy-to-use pen powered by Retatrutide, a triple-receptor peptide at the frontier of weight science.
Retatrutide is a late-stage investigational peptide showing highly promising results in weight management, while full regulatory approval is still pending.
The Science
Targeting Fat Differently
Retatrutide works across three key receptors, GLP 1, GIP and glucagon, which are linked to hunger, metabolism and how your body uses energy, helping support meaningful weight loss.
Published Phase 2 evidence
Results shown are from the 12 mg group in a published 48-week Phase 2 obesity trial. Individual outcomes vary. Read the peer-reviewed paper
Ongoing research: Retatrutide remains investigational and additional Phase 3 studies continue. View registered trials
The Results
Progress,
illustrated.
−12%
I had almost accepted that losing weight would always be a struggle. Now, I am lot lighter and feel better in my own body. I finally feel proud of my progress.
−15%
I was surprised by how quickly I started seeing progress with Serenovo. I feel healthier and more confident.
−18%
The change is honestly night and day. My weight is down, my clothes fit completely differently, and the physical difference is obvious when I compare photos. I didn’t expect to see this much progress.
−20%
Honestly, I wasn’t expecting the results to be this noticeable. I started seeing changes and was kind of shocked by how much progress I’d made.
−17%
What surprised me was how consistent the progress felt. Most weeks the scale was moving, my appetite was way more manageable, and I wasn’t thinking about food all day. After a while, the difference really started adding up.
−15%
The weird part is that losing weight stopped feeling like this huge project I had to manage all the time. I just got into a better rhythm with food, stayed consistent, and the weight came down. I’m really happy with where I ended up.
Check Out
Your next chapter starts here
Explore two prototype support plans. This interface is illustrative and is not an offer to purchase or obtain Retatrutide.
Your monthly plan includes
Monthly Serenovo Pen 20 mg delivery Preferred subscription pricing Ongoing support Cancel anytimeYour selection
01 / 02Review your plan
This market is not available yet.
Shop ColombiaHow it works
Real science.
Real progress.
Retatrutide is being studied for how triple-receptor activity may influence appetite, metabolism, and energy balance.
- 1
Get ready
Review your study team's instructions and get your pen and supplies ready.
- 2
Choose your spot
Choose and prepare the area recommended by your study team.
- 3
Inject with ease
Follow the pen demonstration from your study team, at your own pace.
- 4
Stay on track
Record your scheduled use and questions ahead of your next check-in.
Investigational use only.
These images and steps are illustrative and are not instructions for use. Trial participants should follow their study team’s directions.
Questions, clearly answered
The essential
context.
Measured answers for an investigational therapy and a prototype experience.
Buy Now
About us
A healthier tomorrow.
A healthier tomorrow.
By design.
Serenovo began with a simple belief: progress starts with understanding. We bring a thoughtful perspective to emerging science, making room for clear information, informed choices and a more considered approach to wellbeing.
Research led
Curiosity grounded in evidence.
Clarity first
Careful questions. Clear information.
People at heart
A considered view of wellbeing.
Human potential. Backed by science.